Metraipolis › archive › dc_5a7c00a114a3

Urease inhibitors: current advances, therapeutic potentials, and clinical challenges — Europe PMC PMID:42290516

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42290516
DOI: 10.1080/17568919.2026.2684497
License (as archived): solo-consultazione
Archived: 2026-10-31T11:11:26.709Z
SHA-256 of the archived text: 29921b9368e7001037b37120e831112a48d58cf4c3f8d7faea0edc5d5e6137f8
Stable URL of this page: https://metraipolis.com/documento/dc_5a7c00a114a3

How to cite

Urease inhibitors: current advances, therapeutic potentials, and clinical challenges — Europe PMC PMID:42290516 — Europe PMC (en), https://europepmc.org/article/MED/42290516 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a7c00a114a3 (Metraipolis archive dc_5a7c00a114a3, sha256 29921b9368e7001037b37120e831112a48d58cf4c3f8d7faea0edc5d5e6137f8)

BibTeX

@misc{dc5a7c00a114a3,
  title = {Urease inhibitors: current advances, therapeutic potentials, and clinical challenges — Europe PMC PMID:42290516},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42290516},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a7c00a114a3; sha256 29921b9368e7001037b37120e831112a48d58cf4c3f8d7faea0edc5d5e6137f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42290516. Agents can read the archived copy with the MCP tool read_document.